These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16712494)

  • 1. The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease.
    Catalano SM; Dodson EC; Henze DA; Joyce JG; Krafft GA; Kinney GG
    Curr Top Med Chem; 2006; 6(6):597-608. PubMed ID: 16712494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
    J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs).
    Viola KL; Velasco PT; Klein WL
    J Nutr Health Aging; 2008 Jan; 12(1):51S-7S. PubMed ID: 18165846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drebrin in Alzheimer's Disease.
    Ishizuka Y; Hanamura K
    Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid β-Derived Diffusible Ligands (ADDLs) Induce Abnormal Autophagy Associated with Aβ Aggregation Degree.
    Wen J; Fang F; Guo SH; Zhang Y; Peng XL; Sun WM; Wei XR; He JS; Hung T
    J Mol Neurosci; 2018 Feb; 64(2):162-174. PubMed ID: 29260451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.
    Gaspar RC; Villarreal SA; Bowles N; Hepler RW; Joyce JG; Shughrue PJ
    Exp Neurol; 2010 Jun; 223(2):394-400. PubMed ID: 19744481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease.
    Look GC; Jerecic J; Cherbavaz DB; Pray TR; Breach JC; Crosier WJ; Igoudin L; Hironaka CM; Lowe RM; McEntee M; Ruslim-Litrus L; Wu HM; Zhang S; Catalano SM; Goure WF; Summa D; Krafft GA
    Curr Alzheimer Res; 2007 Dec; 4(5):562-7. PubMed ID: 18220523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.
    Klein WL
    Neurochem Int; 2002 Nov; 41(5):345-52. PubMed ID: 12176077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
    Gong Y; Chang L; Viola KL; Lacor PN; Lambert MP; Finch CE; Krafft GA; Klein WL
    Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10417-22. PubMed ID: 12925731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies that target pathological assemblies of Abeta.
    Lambert MP; Velasco PT; Chang L; Viola KL; Fernandez S; Lacor PN; Khuon D; Gong Y; Bigio EH; Shaw P; De Felice FG; Krafft GA; Klein WL
    J Neurochem; 2007 Jan; 100(1):23-35. PubMed ID: 17116235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening.
    Chang L; Bakhos L; Wang Z; Venton DL; Klein WL
    J Mol Neurosci; 2003; 20(3):305-13. PubMed ID: 14501013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADDLs and the signaling web that leads to Alzheimer's disease.
    Krafft GA; Klein WL
    Neuropharmacology; 2010; 59(4-5):230-42. PubMed ID: 20650286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease.
    Lee MC; Yu WC; Shih YH; Chen CY; Guo ZH; Huang SJ; Chan JCC; Chen YR
    Sci Rep; 2018 Mar; 8(1):4772. PubMed ID: 29555950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
    Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
    J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
    Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
    Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons.
    Shughrue PJ; Acton PJ; Breese RS; Zhao WQ; Chen-Dodson E; Hepler RW; Wolfe AL; Matthews M; Heidecker GJ; Joyce JG; Villarreal SA; Kinney GG
    Neurobiol Aging; 2010 Feb; 31(2):189-202. PubMed ID: 18486276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.